dc.contributor.author |
Solanki, Geetesh
|
|
dc.contributor.author |
Wilkinson, Thomas
|
|
dc.contributor.author |
Bansal, Shailav
|
|
dc.contributor.author |
Shiba, Joshila
|
|
dc.contributor.author |
Manda, S.O.M. (Samuel)
|
|
dc.contributor.author |
Doherty, Tanya
|
|
dc.date.accessioned |
2022-11-03T12:54:36Z |
|
dc.date.available |
2022-11-03T12:54:36Z |
|
dc.date.issued |
2022-05-05 |
|
dc.description |
SUPPLEMENTARY MATERIAL : S1 Table. Comparison of Discovery Health administration profile versus rest of the rest of the insured population in South Africa.
https://doi.org/10.1371/journal.pone.0268025.s001 |
|
dc.description |
S2 Table. Univariate and multivariate analysis of factors associated with hospitalisation cost with coefficients.
https://doi.org/10.1371/journal.pone.0268025.s002 |
|
dc.description.abstract |
BACKGROUND :
Evidence on the risk factors for COVID-19 hospitalization, mortality, hospital stay and
cost of treatment in the African context is limited. This study aims to quantify the impact of
known risk factors on these outcomes in a large South African private health insured
population.
METHODS AND FINDINGDS :
This is a cross sectional analytic study based on the analysis of the records of members
belonging to health insurances administered by Discovery Health (PTY) Ltd. Demographic
data for 188,292 members who tested COVID-19 positive over the period 1 March 2020–28
February 2021 and the hospitalization data for these members up until 30 June 2021 were
extracted. Logistic regression models were used for hospitalization and death outcomes,
while length of hospital stay and (log) cost per patient were modelled by negative binominal
and linear regression models. We accounted for potential differences in the population
served and the quality of care within different geographic health regions by including the
health district as a random effect. Overall hospitalization and mortality risk was 18.8% and
3.3% respectively. Those aged 65+ years, those with 3 or more comorbidities and males
had the highest hospitalization and mortality risks and the longest and costliest hospital
stays. Hospitalization and mortality risks were higher in wave 2 than in wave 1. Hospital and
mortality risk varied across provinces, even after controlling for important predictors. Hospitalization and mortality risks were the highest for diabetes alone or in combination with
hypertension, hypercholesterolemia and ischemic heart disease.
CONCLUSIONS :
These findings can assist in developing better risk mitigation and management strategies. It
can also allow for better resource allocation and prioritization planning as health systems
struggle to meet the increased care demands resulting from the pandemic while having to
deal with these in an ever-more resource constrained environment. |
en_US |
dc.description.department |
Statistics |
en_US |
dc.description.librarian |
dm2022 |
en_US |
dc.description.sponsorship |
The South African Medical Research Council. |
en_US |
dc.description.uri |
http://www.plosone.org |
en_US |
dc.identifier.citation |
Solanki, G., Wilkinson, T., Bansal, S., Shiba, J., Manda, S. & Doherty, T. (2022) COVID-19 hospitalization and mortality and hospitalizationrelated utilization and expenditure: Analysis of a
South African private health insured population.
PLoS One 17(5): e0268025. https://doi.org/10.1371/journal.pone.0268025. |
en_US |
dc.identifier.issn |
1932-6203 (online) |
|
dc.identifier.other |
10.1371/journal.pone.0268025 |
|
dc.identifier.uri |
https://repository.up.ac.za/handle/2263/88132 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Public Library of Science |
en_US |
dc.rights |
© 2022 Solanki et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License. |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_US |
dc.subject |
Risk factors |
en_US |
dc.subject |
Private healthcare sector |
en_US |
dc.subject |
Cost of treatment |
en_US |
dc.subject |
Hospital stay |
en_US |
dc.subject |
Hospitalization |
en_US |
dc.subject |
Mortality |
en_US |
dc.title |
COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure : analysis of a South African private health insured population |
en_US |
dc.type |
Article |
en_US |